Literature DB >> 23853097

Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin.

Yuwei Zhu1, Jianxin Dai, Tiancheng Zhang, Xu Li, Pengfei Fang, Huajing Wang, Yongliang Jiang, Xiaojie Yu, Tian Xia, Liwen Niu, Yajun Guo, Maikun Teng.   

Abstract

Ricin belongs to the type II ribosome-inactivating proteins that depurinate the universally conserved α-sarcin loop of rRNA. The RNA N-glycosidase activity of ricin also largely depends on the ribosomal proteins that play an important role during the process of rRNA depurination. Therefore, the study of the interaction between ricin and the ribosomal elements will be better to understand the catalysis mechanism of ricin. The antibody 6C2 is a mouse monoclonal antibody exhibiting unusually potent neutralizing ability against ricin, but the neutralization mechanism remains unknown. Here, we report the 2.8 Å crystal structure of 6C2 Fab in complex with the A-chain of ricin (RTA), which reveals an extensive antigen-antibody interface that contains both hydrogen bonds and van der Waals contacts. The complementarity-determining region loops H1, H2, H3, and L3 form a pocket to accommodate the epitope on the RTA (residues Asp(96)-Thr(116)). ELISA results show that Gln(98), Glu(99), Glu(102), and Thr(105) (RTA) are the key residues that play an important role in recognizing 6C2. With the perturbation of the 6C2 Fab-RTA interface, 6C2 loses its neutralization ability, measured based on the inhibition of protein synthesis in a cell-free system. Finally, we propose that the neutralization mechanism of 6C2 against ricin is that the binding of 6C2 hinders the interaction between RTA and the ribosome and the surface plasmon resonance and pulldown results confirm our hypothesis. In short, our data explain the neutralization mechanism of mAb 6C2 against ricin and provide a structural basis for the development of improved antibody drugs with better specificity and higher affinity.

Entities:  

Keywords:  Antibodies; RIP; Ribosomal RNA Processing; Ribosomes; Structural Biology

Mesh:

Substances:

Year:  2013        PMID: 23853097      PMCID: PMC3757180          DOI: 10.1074/jbc.M113.480830

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Genetics of ribosome-inactivating proteins.

Authors:  Martin R Hartley; J Michael Lord
Journal:  Mini Rev Med Chem       Date:  2004-06       Impact factor: 3.862

Review 2.  The history of ricin, abrin and related toxins.

Authors:  Sjur Olsnes
Journal:  Toxicon       Date:  2004-09-15       Impact factor: 3.033

3.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

6.  Determination by systematic deletion of the amino acids essential for catalysis by ricin A chain.

Authors:  K N Morris; I G Wool
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.

Authors:  Joan E Smallshaw; James A Richardson; Seth Pincus; John Schindler; Ellen S Vitetta
Journal:  Vaccine       Date:  2005-09-15       Impact factor: 3.641

8.  Ricin inhibition of in vitro protein synthesis by plant ribosomes.

Authors:  S M Harley; H Beevers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Structure of a ricin mutant showing rescue of activity by a noncatalytic residue.

Authors:  Y Kim; D Mlsna; A F Monzingo; M P Ready; A Frankel; J D Robertus
Journal:  Biochemistry       Date:  1992-03-31       Impact factor: 3.162

10.  Immunological characteristics associated with the protective efficacy of antibodies to ricin.

Authors:  Massimo Maddaloni; Corrie Cooke; Royce Wilkinson; Audrey V Stout; Leta Eng; Seth H Pincus
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  6 in total

1.  Toxicity of ricin A chain is reduced in mammalian cells by inhibiting its interaction with the ribosome.

Authors:  Amanda E Jetzt; Xiao-Ping Li; Nilgun E Tumer; Wendie S Cohick
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-15       Impact factor: 4.219

2.  Baicalin inhibits the lethality of ricin in mice by inducing protein oligomerization.

Authors:  Jing Dong; Yong Zhang; Yutao Chen; Xiaodi Niu; Yu Zhang; Rui Li; Cheng Yang; Quan Wang; Xuemei Li; Xuming Deng
Journal:  J Biol Chem       Date:  2015-04-05       Impact factor: 5.157

3.  Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.

Authors:  Michael J Rudolph; David J Vance; Michael S Cassidy; Yinghui Rong; Nicholas J Mantis
Journal:  J Biol Chem       Date:  2016-11-30       Impact factor: 5.157

4.  Crystal structures of ricin toxin's enzymatic subunit (RTA) in complex with neutralizing and non-neutralizing single-chain antibodies.

Authors:  Michael J Rudolph; David J Vance; Jonah Cheung; Matthew C Franklin; Fiana Burshteyn; Michael S Cassidy; Ebony N Gary; Cristina Herrera; Charles B Shoemaker; Nicholas J Mantis
Journal:  J Mol Biol       Date:  2014-06-04       Impact factor: 5.469

5.  Rapid Detection of Ricin in Serum Based on Cu-Chelated Magnetic Beads Using Mass Spectrometry.

Authors:  Yong-Qiang Zhao; Jian Song; Hong-Li Wang; Bin Xu; Feng Liu; Kun He; Na Wang
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-12       Impact factor: 3.109

Review 6.  Progress and challenges associated with the development of ricin toxin subunit vaccines.

Authors:  David J Vance; Nicholas J Mantis
Journal:  Expert Rev Vaccines       Date:  2016-04-06       Impact factor: 5.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.